Bovine Herpesvirus Type 1 (BHV1) is the aetiological agent of a number of d
iseases and not only of IBR, namely infectious pustular vulvovaginitis (IPV
), infectious balanoposthitis (IBP), conjunctivitis, encephalomyelitis, mas
titis, abortion, enteritis, and lesions in the interdigital space. The sero
logical identical strains differ, however, in some aspects. Typical genital
strains usually cause a mild illness, sometimes not even detected clinical
ly, but serologically. They hamper eradication programmes and do not cause
IBR when inoculated intranasally. The other - modern - strains are, however
, always able to induce a severe disease in the genital tracts. But infecti
on of field or vaccine virus leads to the development of humoral and cell-m
ediated immunity. The latter is, however, not transmitted to neonates via c
olostrum. BHV1 antibodies can be found in bovines in all continents, and in
many wild species. Prevalences vary greatly depending on herd size and man
agement. Because seronegative cattle play a role in international trade a n
umber of European countries have eradicated BHV1, with very high costs invo
lved. Marker and conventional vaccines can prevent disease but not infectio
n followed by the state of latency. The genomes of several strains, includi
ng the marker strains can remain latent in the same animal and be reactivat
ed after stress or Injection of corticosteroids. For the detection of humor
al antibodies the ELISA is widely used. It is useful for testing bulk milk
samples for antibodies derived from field virus and conventional vaccines b
ut not from gE-deleted marker vaccines. Importing countries should consider
only vaccinated animals for import. They should require that the animals a
re seronegative prior to vaccination.